American pharmaceutical company Pfiza, one of the world leaders in this industry, from January to September 2018, increased its net profit by 28% in annual terms to 11 billion 546 million dollars, finversia.ru writes, referring to the company's statements. Earnings per share rose to 1 dollar 92 cents from 1 dollar 49 cents a year earlier. Revenue increased by 2% and amounted to 39 billion 700 million dollars. In the third quarter, Pfiza net profit increased 1.5 times, and its revenue increased by 1%. At the same time, in the sector of basic medical goods and services a decrease by 4% was observed.
Asian shares to record first monthly loss on bond rout26.03.2021
Gold retreats to record its first weekly decline in three as U.S. Treasury yields rise23.03.2021
U.S. air travelers surpass 1.5 million for first time in a year08.03.2021
Brent spikes over $70 for first time since start of pandemic, Saudi facilities attacked